Naringenin derivative and application thereof
A derivative, the technology of naringenin, which is applied in the field of naringenin derivatives, can solve the problems that no one has disclosed the structure of naringenin derivatives, achieve good application prospects, reduce the pain of chemotherapy, and reduce the effect of pain
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Example 1: Compound Y1 preparation of
[0021] Dissolve naringenin (100 mg, 0.37 mmol, 1.0 eq.) in 1 mL DMF, add K 2 CO 3 (153 mg, 1.11 mmol, 3 eq.) was stirred at room temperature for 15 min, and MeI (131 mg, 0.93 mmol, 2.5 eq.) was added and stirred overnight at room temperature, and the reaction was monitored by TLC and LCMS. filter, flash (reverse) (H 2 O / 0.05%FA) / MeCN:25%-65%, 20min) to obtain 1.5 mg of yellow solid, yield 1.4%. Compound structure data characterization: 1 H NMR (500 MHz, DMSO-d6)δ 12.15 (d, J = 8.8 Hz, 1H), 9.55 (s, 1H), 7.22 -7.30 (m, 2H), 6.70 – 6.79(m, 2H), 6.15 ( d, J = 11.0 Hz, 1H), 5.40 (dt, J = 12.3, 2.3 Hz, 1H), 3.62 –3.79 (m, 4H), 2.62 – 2.76 (m, 1H), 1.83 (d, J = 10.0 Hz , 3H). MS (ESI): C 17 h 16 o 5 , Calcd for [M+H] + 301.1071; Found: 301.1.
Embodiment 2
[0022] Example 2: Compound Y2 (naringenin trimethyl ether) preparation of
[0023] Dissolve naringenin (100 mg, 0.37 mmol, 1.0 eq.) in 1 mL DMF, add K 2 CO 3 (153 mg, 1.11 mmol, 3 eq.) was stirred at room temperature for 15 min, and MeI (131 mg, 0.93 mmol, 2.5 eq.) was added and stirred overnight at room temperature, and the reaction was monitored by TLC and LCMS. filter, flash (reverse) (H 2 O / 0.05%FA) / MeCN:25%-65%, 20min) to obtain 13.7 mg of yellow oil, with a yield of 11.8%. Compound structure data characterization: 1 H NMR (500 MHz, DMSO-d6) δ 7.40 – 7.47 (m, 2H), 6.93 – 7.00 (m, 2H), 6.17 – 6.23 (m, 2H), 5.46(dd, J = 12.7, 2.9 Hz, 1H ), 3.75 – 3.84 (m, 9H), 3.01 – 3.11 (m, 1H), 2.56 –2.63 (m, 1H). MS (ESI): C 18 h 18 o 5 , Calcd for [M+H] + 315.1227; Found: 315.1.
Embodiment 3
[0024] Example 3: Compound Y3 (4',7-Dimethylnaringenin) preparation of
[0025] Dissolve naringenin (100 mg, 0.37 mmol, 1.0 eq.) in 1 mL DMF, add K 2 CO 3 (153 mg, 1.11 mmol, 3 eq.) was stirred at room temperature for 15 min, and MeI (131 mg, 0.93 mmol, 2.5 eq.) was added and stirred overnight at room temperature, and the reaction was monitored by TLC and LCMS. filter, flash (reverse) (H 2 O / 0.05%FA) / MeCN:25%-65%, 20min) to obtain 3.8mg of 3 yellow solids, yield 3.4%. Compound structure data characterization: 1H NMR (500 MHz, DMSO-d6)δ 12.04 (s, 1H), 7.35 – 7.42 (m, 2H), 6.88 – 6.95 (m, 2H), 6.03 (dd, J =15.2, 2.3 Hz, 2H), 5.49 (dd, J = 12.7, 3.0 Hz, 1H), 3.71 (d, J = 8.2 Hz, 6H), 3.22 – 3.29 (m, 1H), 2.66 – 2.73 (m, 1H). MS (ESI): C 17 h 16 o 5 , Calcd for [M+H] + 301.1071; Found: 301.1.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


